Onyx Pharmaceuticals to Webcast Analyst Briefing
June 01 2006 - 4:00PM
PR Newswire (US)
Meeting Scheduled for June 8, 2006 EMERYVILLE, Calif., June 1
/PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)
today announced today that it will webcast a post-ASCO analyst
briefing on Thursday, June 8, 2006, beginning at 4:30 p.m. Eastern
Time. Clinical investigators and management will participate in the
event. The physicians will review recently reported clinical data
for Nexavar(R) (sorafenib) tablets, being developed in
collaboration with Bayer Pharmaceuticals Corporation. Interested
parties may access a live webcast of the presentation by clicking
on the link below:
http://phx.corporate-ir.net/phoenix.zhtml?p=irol-
eventDetails&c=112065&eventID=1318003 or by dialing
617-213-8063 and using the passcode 71300692. A replay of the
presentation will be available on the Onyx website through July 8,
2006. Onyx Pharmaceuticals is engaged in the development of novel
cancer therapies that target the molecular basis of cancer. With
its collaborators, the company is developing small molecule drugs,
including Nexavar(R) (sorafenib) tablets with Bayer Pharmaceuticals
Corporation. For more information about Onyx's pipeline and
activities, visit the company's website at
http://www.onyx-pharm.com/. NOTE: Nexavar(R) (sorafenib) tablets is
a registered trademark of Bayer Pharmaceuticals Corporation.
DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alex Santos of Onyx
Pharmaceuticals, +1-510-597-6504 Web site:
http://www.onyx-pharm.com/
Copyright
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals (MM) News Articles